187 related articles for article (PubMed ID: 23555599)
1. The p14ARF alternate reading frame protein enhances DNA binding of topoisomerase I by interacting with the serine 506-phosphorylated core domain.
Bandyopadhyay K; Li P; Gjerset RA
PLoS One; 2013; 8(3):e58835. PubMed ID: 23555599
[TBL] [Abstract][Full Text] [Related]
2. CK2-mediated hyperphosphorylation of topoisomerase I targets serine 506, enhances topoisomerase I-DNA binding, and increases cellular camptothecin sensitivity.
Bandyopadhyay K; Li P; Gjerset RA
PLoS One; 2012; 7(11):e50427. PubMed ID: 23185622
[TBL] [Abstract][Full Text] [Related]
3. Protein kinase CK2 is a central regulator of topoisomerase I hyperphosphorylation and camptothecin sensitivity in cancer cell lines.
Bandyopadhyay K; Gjerset RA
Biochemistry; 2011 Feb; 50(5):704-14. PubMed ID: 21182307
[TBL] [Abstract][Full Text] [Related]
4. Delineation of the domains required for physical and functional interaction of p14ARF with human topoisomerase I.
Ayrault O; Karayan L; Riou JF; Larsen CJ; Séité P
Oncogene; 2003 Apr; 22(13):1945-54. PubMed ID: 12673200
[TBL] [Abstract][Full Text] [Related]
5. Serine phosphorylation-dependent coregulation of topoisomerase I by the p14ARF tumor suppressor.
Bandyopadhyay K; Lee C; Haghighi A; Banères JL; Parello J; Gjerset RA
Biochemistry; 2007 Dec; 46(49):14325-34. PubMed ID: 18004878
[TBL] [Abstract][Full Text] [Related]
6. Human ARF protein interacts with topoisomerase I and stimulates its activity.
Karayan L; Riou JF; Séité P; Migeon J; Cantereau A; Larsen CJ
Oncogene; 2001 Feb; 20(7):836-48. PubMed ID: 11314011
[TBL] [Abstract][Full Text] [Related]
7. Human Arf tumor suppressor specifically interacts with chromatin containing the promoter of rRNA genes.
Ayrault O; Andrique L; Larsen CJ; Seite P
Oncogene; 2004 Oct; 23(49):8097-104. PubMed ID: 15361825
[TBL] [Abstract][Full Text] [Related]
8. Mitotic phosphorylation stimulates DNA relaxation activity of human topoisomerase I.
Hackbarth JS; Galvez-Peralta M; Dai NT; Loegering DA; Peterson KL; Meng XW; Karnitz LM; Kaufmann SH
J Biol Chem; 2008 Jun; 283(24):16711-22. PubMed ID: 18408216
[TBL] [Abstract][Full Text] [Related]
9. A casein kinase type II (CKII)-like nuclear protein kinase associates with, phosphorylates, and activates topoisomerase I.
Turman MA; Douvas A
Biochem Med Metab Biol; 1993 Oct; 50(2):210-25. PubMed ID: 8260198
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of DNA topoisomerase I by the c-Abl tyrosine kinase confers camptothecin sensitivity.
Yu D; Khan E; Khaleque MA; Lee J; Laco G; Kohlhagen G; Kharbanda S; Cheng YC; Pommier Y; Bharti A
J Biol Chem; 2004 Dec; 279(50):51851-61. PubMed ID: 15448168
[TBL] [Abstract][Full Text] [Related]
11. Activities of topoisomerase I in its complex with SRSF1.
Ishikawa T; Krzysko KA; Kowalska-Loth B; Skrajna AM; Czubaty A; Girstun A; Cieplak MK; Lesyng B; Staron K
Biochemistry; 2012 Feb; 51(8):1803-16. PubMed ID: 22320324
[TBL] [Abstract][Full Text] [Related]
12. Casein kinase II-dependent phosphorylation of DNA topoisomerase II suppresses the effect of a catalytic topo II inhibitor, ICRF-193, in fission yeast.
Nakazawa N; Arakawa O; Ebe M; Yanagida M
J Biol Chem; 2019 Mar; 294(10):3772-3782. PubMed ID: 30635402
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of serine 1106 in the catalytic domain of topoisomerase II alpha regulates enzymatic activity and drug sensitivity.
Chikamori K; Grabowski DR; Kinter M; Willard BB; Yadav S; Aebersold RH; Bukowski RM; Hickson ID; Andersen AH; Ganapathi R; Ganapathi MK
J Biol Chem; 2003 Apr; 278(15):12696-702. PubMed ID: 12569090
[TBL] [Abstract][Full Text] [Related]
14. DNA damage disrupts the p14ARF-B23(nucleophosmin) interaction and triggers a transient subnuclear redistribution of p14ARF.
Lee C; Smith BA; Bandyopadhyay K; Gjerset RA
Cancer Res; 2005 Nov; 65(21):9834-42. PubMed ID: 16267006
[TBL] [Abstract][Full Text] [Related]
15. Pea DNA topoisomerase I is phosphorylated and stimulated by casein kinase 2 and protein kinase C.
Tuteja N; Reddy MK; Mudgil Y; Yadav BS; Chandok MR; Sopory SK
Plant Physiol; 2003 Aug; 132(4):2108-15. PubMed ID: 12913165
[TBL] [Abstract][Full Text] [Related]
16. Retinoic acid and phorbol ester induced hyperphosphorylation of topoisomerase II-alpha is an early event in HL-60 human leukaemia cell differentiation: effect on topoisomerase activity and etoposide sensitivity.
Chresta CM; Hall BF; Francis GE
Leukemia; 1995 Aug; 9(8):1373-81. PubMed ID: 7643627
[TBL] [Abstract][Full Text] [Related]
17. MDM2-mediated degradation of p14ARF: a novel mechanism to control ARF levels in cancer cells.
Vivo M; Matarese M; Sepe M; Di Martino R; Festa L; Calabrò V; La Mantia G; Pollice A
PLoS One; 2015; 10(2):e0117252. PubMed ID: 25723571
[TBL] [Abstract][Full Text] [Related]
18. Defining the molecular basis of Arf and Hdm2 interactions.
Bothner B; Lewis WS; DiGiammarino EL; Weber JD; Bothner SJ; Kriwacki RW
J Mol Biol; 2001 Nov; 314(2):263-77. PubMed ID: 11718560
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation of p53 on Ser15 during cell cycle caused by Topo I and Topo II inhibitors in relation to ATM and Chk2 activation.
Zhao H; Traganos F; Darzynkiewicz Z
Cell Cycle; 2008 Oct; 7(19):3048-55. PubMed ID: 18802408
[TBL] [Abstract][Full Text] [Related]
20. Casein kinase I delta/epsilon phosphorylates topoisomerase IIalpha at serine-1106 and modulates DNA cleavage activity.
Grozav AG; Chikamori K; Kozuki T; Grabowski DR; Bukowski RM; Willard B; Kinter M; Andersen AH; Ganapathi R; Ganapathi MK
Nucleic Acids Res; 2009 Feb; 37(2):382-92. PubMed ID: 19043076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
